Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Aubreyon Apr 05, 2015 10:51am

86 Views

Post# 23598284

RE:RE:RE:RE:RE:lets not get paranoid about terms

Fred, I would also like to hear conformation from the office that Rutherrin will be used. I can't think of a solid reason why Rutherrin wouldn't be used..but you are right..if Rutherrin wasn't used then this knowledge would reveal a hidden snag.
We had $600,000 budgeted for the tox. study...how much do we have budgeted for investor relations to answer intelligent questions like the one you brought up?

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario